Sabra Healthcare REIT (NASDAQ:SBRA) Given New $23.00 Price Target at Citizens Jmp

Sabra Healthcare REIT (NASDAQ:SBRA) had its target price hoisted by investment analysts at Citizens Jmp from $22.00 to $23.00 in a report issued on Wednesday,Benzinga reports. The firm presently has a “market outperform” rating on the real estate investment trust’s stock. Citizens Jmp’s price objective points to a potential upside of 11.80% from the stock’s current price.

A number of other equities analysts also recently weighed in on the stock. Wells Fargo & Company boosted their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. Wall Street Zen cut Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research note on Friday, January 23rd. Citigroup restated a “buy” rating on shares of Sabra Healthcare REIT in a research note on Wednesday. UBS Group assumed coverage on shares of Sabra Healthcare REIT in a research note on Tuesday, November 18th. They issued a “neutral” rating and a $20.00 price objective for the company. Finally, Cantor Fitzgerald increased their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a report on Tuesday. Five analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, Sabra Healthcare REIT currently has an average rating of “Moderate Buy” and a consensus price target of $21.33.

Sabra Healthcare REIT Stock Down 0.1%

NASDAQ SBRA traded down $0.02 during trading hours on Wednesday, hitting $20.57. The company’s stock had a trading volume of 99,395 shares, compared to its average volume of 2,814,905. Sabra Healthcare REIT has a 52 week low of $15.60 and a 52 week high of $20.70. The company has a current ratio of 4.29, a quick ratio of 4.29 and a debt-to-equity ratio of 0.90. The company’s 50-day simple moving average is $19.08 and its two-hundred day simple moving average is $18.80. The company has a market capitalization of $5.13 billion, a PE ratio of 32.17, a price-to-earnings-growth ratio of 1.42 and a beta of 0.67.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.26). Sabra Healthcare REIT had a return on equity of 5.63% and a net margin of 20.09%.The company had revenue of $201.35 million for the quarter, compared to the consensus estimate of $201.97 million. During the same quarter last year, the company posted $0.36 EPS. The company’s quarterly revenue was up 16.2% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Research analysts anticipate that Sabra Healthcare REIT will post 1.45 EPS for the current fiscal year.

Institutional Investors Weigh In On Sabra Healthcare REIT

Institutional investors have recently made changes to their positions in the business. Rothschild Investment LLC raised its position in Sabra Healthcare REIT by 164.6% in the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock worth $27,000 after purchasing an additional 889 shares during the period. Smartleaf Asset Management LLC increased its holdings in shares of Sabra Healthcare REIT by 97.7% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock worth $27,000 after buying an additional 714 shares during the period. Founders Capital Management bought a new stake in shares of Sabra Healthcare REIT in the 3rd quarter valued at about $28,000. Strengthening Families & Communities LLC bought a new stake in shares of Sabra Healthcare REIT in the 4th quarter valued at about $29,000. Finally, Danske Bank A S purchased a new stake in Sabra Healthcare REIT during the 3rd quarter valued at about $30,000. Hedge funds and other institutional investors own 99.40% of the company’s stock.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.